Cost-effectiveness of risk stratified medication management for reducing premature cardiovascular mortality in Kenya.
<h4>Background</h4>Cardiovascular disease (CVD) is a major contributor to the burden from non-communicable diseases in Sub-Saharan Africa and hypertension is the leading risk factor for CVD. The objective of this modeling study is to assess the cost-effectiveness of a risk stratified app...
Main Authors: | Sujha Subramanian, Rainer Hilscher, Robai Gakunga, Breda Munoz, Elijah Ogola |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2019-01-01
|
Series: | PLoS ONE |
Online Access: | https://doi.org/10.1371/journal.pone.0218256 |
Similar Items
-
Correction: Cost-effectiveness of risk stratified medication management for reducing premature cardiovascular mortality in Kenya.
by: PLOS ONE Staff
Published: (2020-01-01) -
Establishing Cohorts to Generate the Evidence Base to Reduce the Burden of Breast Cancer in Sub-Saharan Africa: Results From a Feasibility Study in Kenya
by: Sujha Subramanian, et al.
Published: (2019-03-01) -
Cost and affordability of non-communicable disease screening, diagnosis and treatment in Kenya: Patient payments in the private and public sectors.
by: Sujha Subramanian, et al.
Published: (2018-01-01) -
Stroke Mortality in Kenya’s Public Tertiary Hospitals: A Prospective Facility-Based Study
by: Lydia Kaduka, et al.
Published: (2018-06-01) -
The cost of beauty: Perspectives of salon workers in Kisumu City, Kenya
by: Patrick Ogola Onyango
Published: (2023-01-01)